热门资讯> 正文
Actuate Therapeutics提交2.5亿美元混合证券货架
2025-09-03 04:35
- Actuate Therapeutics (NASDAQ:ACTU) filed a prospectus for the offer and sale of $250M mixed securities shelf.
- This prospectus is not an offer to sell these securities.
- Filing.
More on Actuate Therapeutics, Inc.
- Actuate: Elraglusib Continues To Deliver And Next Catalyst Is FDA Type B Meeting
- Seeking Alpha’s Quant Rating on Actuate Therapeutics, Inc.
- Historical earnings data for Actuate Therapeutics, Inc.
- Financial information for Actuate Therapeutics, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
